• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Proveris Scientific
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Summit Biosciences expansion nearing completion

Nasal spray CDMO Summit Biosciences has nearly completed a $19 million expansion of its facility at the University of Kentucky Coldstream Research Campus that is expected to create 78 jobs, the state of Kentucky has announced. Following the expansion, which includes laboratory, warehouse, and manufacturing space, the facility will total 44,000 sq ft.

The company, which currently employs 125 people, has been granted up to $1.5 million in tax incentives based on the investment and on creating and maintaining the 78 positions for 10 years at an average pay rate of $28/hour.

In May 2020, Atossa Therapeutics announced that Summit would provide development and manufacturing services for Atossa’s AT-301 nasal spray for the treatment and possible prevention of COVID-19.

Summit President and Chief Operating Officer Greg Plucinski commented, “We are excited and honored to have been entrusted by Atossa Therapeutics to aid in the development of a product that could potentially be used in the global fight against the coronavirus. Our dedicated, high-performing team has taken this immense responsibility and worked extremely hard to deliver products for the start of human clinical studies in record time.”

Read the Kentucky press release.

Share

published on September 29, 2020

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • May 6-May 9: RDD Europe 2025, Estoril, Portugal
  • May 13-May 14: Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course 24, online
  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Solstice Air banner
    © 2025 OINDPnews